Skip to content

Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease

Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00298129
Enrollment
278
Registered
2006-03-01
Start date
2004-02-29
Completion date
2006-12-31
Last updated
2007-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Essential Hypertension, Renal Failure, Chronic Nephropathy

Brief summary

Many patients with chronic renal disease show a loss of the nocturnal decline of blood pressure (non-dipper). However, the mechanism is not yet fully understood. We evaluate 24-hour blood pressure in patients with chronic renal disease using an ambulatory blood pressure monitoring device (A & D TM2425). We also analyze the power spectrum of heart rate variability as an index of autonomic cardiovascular modulation using the same device.

Detailed description

The ratio of lower frequency (LF) and higher frequency (HF) heart rate rhythmic oscillations is expressed as an index of sympathovagal balance. Patients with chronic renal disease participate in the study. Blood pressure and power spectrum of heart rate variability for 24 hours are measured when they receive no medication for at least 1 week. The mean waking and sleeping time systolic and diastolic blood pressure are calculated. LF/HF ratios in the chronic renal disease are evaluated to calculate the waking/sleeping ratio for LF/HF.

Interventions

Sponsors

Yokohama City University Medical Center
Lead SponsorOTHER

Study design

Observational model
NATURAL_HISTORY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Hypertensive patients with diabetes mellitus * Hypertensive patients * Hypertensive patients with renal disease * Patients with chronic renal disease

Exclusion criteria

* Cardiac, hematologic or hepatic disease * Cerebral infarction or hemorrhage * Other major diseases.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026